Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2021 1
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
GoPeaks: histone modification peak calling for CUT&Tag.
Yashar WM, Kong G, VanCampen J, Curtiss BM, Coleman DJ, Carbone L, Yardimci GG, Maxson JE, Braun TP. Yashar WM, et al. Among authors: curtiss bm. Genome Biol. 2022 Jul 4;23(1):144. doi: 10.1186/s13059-022-02707-w. Genome Biol. 2022. PMID: 35788238 Free PMC article.
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors.
Braun TP, Estabrook J, Schonrock Z, Curtiss BM, Darmusey L, Macaraeg J, Enright T, Coblentz C, Callahan R, Yashar W, Taherinasab A, Mohammed H, Coleman DJ, Druker BJ, Demir E, Lusardi TA, Maxson JE. Braun TP, et al. Among authors: curtiss bm. Leukemia. 2023 Feb;37(2):478-487. doi: 10.1038/s41375-022-01792-x. Epub 2022 Dec 16. Leukemia. 2023. PMID: 36526735 Free PMC article.
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.
Curtiss BM, VanCampen J, Macaraeg J, Kong GL, Taherinasab A, Tsuchiya M, Yashar WM, Tsang YH, Horton W, Coleman DJ, Estabrook J, Lusardi TA, Mills GB, Druker BJ, Maxson JE, Braun TP. Curtiss BM, et al. Leukemia. 2022 Jul;36(7):1781-1793. doi: 10.1038/s41375-022-01594-1. Epub 2022 May 19. Leukemia. 2022. PMID: 35590033 Free PMC article.
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
Braun TP, Okhovat M, Coblentz C, Carratt SA, Foley A, Schonrock Z, Curtiss BM, Nevonen K, Davis B, Garcia B, LaTocha D, Weeder BR, Grzadkowski MR, Estabrook JC, Manning HG, Watanabe-Smith K, Jeng S, Smith JL, Leonti AR, Ries RE, McWeeney S, Di Genua C, Drissen R, Nerlov C, Meshinchi S, Carbone L, Druker BJ, Maxson JE. Braun TP, et al. Among authors: curtiss bm. Nat Commun. 2022 Jun 16;13(1):3471. doi: 10.1038/s41467-022-30987-0. Nat Commun. 2022. PMID: 35710794 Free PMC article. No abstract available.
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
Braun TP, Okhovat M, Coblentz C, Carratt SA, Foley A, Schonrock Z, Curtiss BM, Nevonen K, Davis B, Garcia B, LaTocha D, Weeder BR, Grzadkowski MR, Estabrook JC, Manning HG, Watanabe-Smith K, Jeng S, Smith JL, Leonti AR, Ries RE, McWeeney S, Di Genua C, Drissen R, Nerlov C, Meshinchi S, Carbone L, Druker BJ, Maxson JE. Braun TP, et al. Among authors: curtiss bm. Nat Commun. 2019 Nov 29;10(1):5455. doi: 10.1038/s41467-019-13364-2. Nat Commun. 2019. PMID: 31784538 Free PMC article.
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.
Braun TP, Coblentz C, Curtiss BM, Coleman DJ, Schonrock Z, Carratt SA, Callahan RL, Maniaci B, Druker BJ, Maxson JE. Braun TP, et al. Among authors: curtiss bm. Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13670-13679. doi: 10.1073/pnas.1918307117. Epub 2020 May 29. Proc Natl Acad Sci U S A. 2020. PMID: 32471953 Free PMC article.
11 results